http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2234296-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-00 |
| filingDate | 2003-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25a93fe55297e2c0319ce16e4c20c1d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e304cdbbabf93e44b60eb3b8027458b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c884315674d21cf27eefe2a9eb8d1dd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a85d663f9ac6400c82256504c7f8c9b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d048edb59deb0394b39b5e48d015377f |
| publicationDate | 2004-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2234296-C1 |
| titleOfInvention | Method for surgical nonpenetrating treatment of glaucoma |
| abstract | FIELD: medicine, ophthalmology. n SUBSTANCE: one should form surface scleral fragment, dissect deep scleral fragment, remove external wall of Schlemm's canal and corneoscleral tissue. Into the bottom developed one should place polymeric elastic magnetic explantodrainage with longitudinal microhollows applied at its both surfaces and at induction of direct multipolar magnetic field being 0.3-1.65 mTl. On the 3d - 10 th d after operation one should perform the impact onto explantodrainage with external rotating direct magnetic field at induction of 0.05-0.55 Tl. Periodicity of external impact is 1-2 times daily, duration - 1-6 min. Explantodrainage could be designed out of biodestructive material. Repeated external impacts due to magnetic field could be performed in 25-30 d. Explantodrainage could be of round or trapezoidal shape, the size being 1.0-1.5 mm per 3.5-4.0 mm, thickness being 0.10-0.30. The method enables to prevent scaring process in the pathways of IOP outflow, increase the degree of stabilization of microcirculation processes and prevent excessive filtration of liquid in early postoperational period. n EFFECT: higher efficiency of therapy. n 4 cl, 3 ex |
| priorityDate | 2003-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.